Welcome to our dedicated page for Agilent Technologies SEC filings (Ticker: A), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Agilent Technologies Inc. filings document financial reporting and governance matters for an analytical and clinical laboratory technology company. Form 8-K reports include quarterly financial-result releases, Regulation FD disclosures, non-GAAP measure explanations, executive officer transitions, compensatory arrangements and amendments to charter and bylaws.
Proxy and annual-meeting filings cover director elections, stockholder voting, executive compensation, equity awards and the phased declassification of the board. The records also identify governance changes tied to the company’s Delaware certificate of incorporation and bylaws, together with furnished press releases and related exhibits.
Rataj Sue H. reported acquisition or exercise transactions in this Form 4 filing.
AGILENT TECHNOLOGIES, INC. director Sue H. Rataj received an award of 2,158 shares of common stock on March 19, 2026. The shares were granted as compensation for service as a non-employee director and were fully vested upon grant at a reference price of $111.75 per share. Following this award, she directly holds 23,617 shares of Agilent common stock.
Agilent Technologies director Otis W. Brawley received two awards of common stock on March 19, 2026, acquiring 2,158 and 888 shares as compensation grants at a reference price of $111.75 per share. These are non-employee director awards that are fully vested upon grant.
According to the footnotes, Brawley elected to defer receipt of these shares into a deferral account under Agilent’s deferred compensation arrangements, rather than taking the stock immediately. After these transactions, his directly held and deferred Agilent common stock position reported in this filing totals 13,873.623 shares.
AGILENT TECHNOLOGIES, INC. director George A. Scangos reported equity awards of common stock. On 2026-03-19, he received two grants of Agilent common stock as a non-employee director, covering 2,158 shares and 1,057 shares at a reference price of $111.75 per share.
The awards are fully vested upon grant, and he has elected to defer receipt of these shares into a deferral account under Agilent’s 2005 Deferred Compensation Plan for Non-Employee Directors. A footnote also states that 148.973 shares were acquired through Agilent’s dividend reinvestment plan and likewise deferred.
After these transactions, Scangos holds 23,857.047 Agilent shares directly in deferred accounts and an additional 17,893 shares indirectly through the George A. Scangos and Leslie S. Wilson Family Trust. These transactions reflect compensation and deferral elections rather than open-market buying or selling.
Agilent Technologies director Pascal Soriot reported a routine equity compensation event. He received 2,158 shares of Agilent common stock as a fully vested stock award for non-employee directors at a reference price of $111.75 per share. To cover tax obligations on the vesting of restricted stock units, he surrendered 648 shares back to Agilent under Rule 16b-3, a tax-withholding disposition rather than a market sale. After these transactions, he directly holds 2,683 shares of Agilent common stock.
Agilent Technologies director Wilson Dow reported receiving an award of 2,158 shares of common stock on March 19, 2026 at a reference price of $111.75 per share. This was a fully vested stock grant for non-employee directors, classified as a compensation-related acquisition rather than an open-market purchase.
After the award, Dow directly holds 20,368.606 shares of Agilent common stock. A footnote also states that 144.124 shares were acquired through the company’s dividend reinvestment plan and have been deferred by the reporting person.
Podolsky Daniel K reported acquisition or exercise transactions in this Form 4 filing.
Agilent Technologies director Daniel K. Podolsky received a grant of 2,158 shares of common stock valued at $111.75 per share. The award was made as compensation for non-employee directors and is fully vested upon grant. Podolsky elected to defer receipt of these shares, meaning delivery is postponed under Agilent’s deferral arrangements.
Following this award and prior dividend reinvestment activity noted in the footnotes, Podolsky now holds 38,179.908 shares of Agilent common stock in total.
Agilent Technologies director Koh Boon Hwee received an award of 2,158 shares of common stock valued at $111.75 per share as compensation for non-employee directors, fully vested upon grant. In connection with this award and vesting of restricted stock units, he surrendered 648 shares to Agilent to cover tax liabilities.
Footnotes note an additional 106.132 shares acquired through the dividend reinvestment plan, which he has elected to defer. After these transactions, Koh directly holds 63,184.351 shares of Agilent common stock.
Agilent Technologies director Mikael Dolsten received a stock award, increasing his holdings. He was granted 2,158 shares of Agilent common stock at a value of $111.75 per share as a fully vested award for non-employee directors. Following the grant, he directly holds 7,138.2100 shares of common stock. Dolsten elected to defer receipt of 1,079 of the granted shares, and an additional 7.182 shares were acquired and deferred through the company’s dividend reinvestment plan.
Agilent Technologies director Judy L. Brown received a stock award of 2,158 shares of common stock on March 19, 2026. The award for non-employee directors is fully vested upon grant and was valued at $111.75 per share. Following this grant, Brown directly owns 3,835 Agilent shares. This is a compensation-related share acquisition rather than an open-market purchase.
Agilent Technologies director receives stock award
Agilent Technologies director Mala Anand acquired 2,158 shares of common stock on an award valued at $111.75 per share. The footnote explains this was a fully vested stock grant for non-employee directors, meaning it is compensation, not an open-market purchase. After the award, Anand directly holds 16,705 Agilent shares.